STAT

APRIL 13, 2025

In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest pharmacy benefit managers in the United States, violated state laws in its dealings with pharmacies, according to newly released documents.

Specialty Pharmacies 363

Specialty Pharmacies Documentation Drug Pricing 363

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. Click here to see the original post from April 2024.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Documentation 52

Drug Channels

JULY 21, 2020

Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. Hospitals are the primary 340B covered entities that engage with these specialty pharmacies.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Documentation Hospitals 52

Proxsys Rx

APRIL 1, 2025

Regardless of your answer, theres no question the 340B Drug Pricing Program remains a critical resource for eligible healthcare providers, enabling them to stretch scarce federal resources to provide essential services to underserved communities. Perform self-audits to proactively identify and address your 340B program gaps.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Documentation Drug Pricing 52

Drug Channels

MARCH 15, 2022

Pharmacies and Pharmacy Benefit Managers , our 13th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. The 2022 Economic Report on U.S. The chart below illustrates the depth and breadth of the 2022 edition.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). This includes collecting data on utilization management practices, formulary changes, and patient experiences.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Proxsys Rx

APRIL 19, 2024

HRSA issues “Administrative Dispute Resolution” ruling On April 19, HRSA issued a ruling entitled “340B Drug Pricing Program; Administrative Dispute Resolution.” Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52